LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a/RREB1 positive feedback loop and a ceRNA network.

Dong, Qingzhuo; Qiu, Hui; Piao, Chiyuan; Li, Zhengxiu; Cui, Xiaolu

Dong, Qingzhuo; Qiu, Hui; Piao, Chiyuan; Li, Zhengxiu; Cui, Xiaolu.

Afiliación

Dong Q; Department of Urology, First Hospital of China Medical University, #155 Nanjing North Road, Shenyang, 110001, China.
Qiu H; Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Piao C; Department of Urology, First Hospital of China Medical University, #155 Nanjing North Road, Shenyang, 110001, China.
Li Z; Department of Dermatology, First Hospital of China Medical University, Shenyang, 110001, China.
Cui X; Department of Urology, First Hospital of China Medical University, #155 Nanjing North Road, Shenyang, 110001, China. cuixl@cmu1h.com.

J Exp Clin Cancer Res ; 42(1): 209, 2023 Aug 18.

Article en En | MEDLINE | ID: mdl-37596700

Asunto(s)

Neoplasias de la Próstata; ARN Largo no Codificante; Humanos; Masculino; Persona de Mediana Edad; Supervivencia Celular; Proteínas de Unión al ADN; Retroalimentación; Neoplasias de la Próstata/tratamiento farmacológico; Neoplasias de la Próstata/genética; ARN Largo no Codificante/genética; Factores de Transcripción

Palabras clave

Enzalutamide resistance; Prostate cancer; RRM2; SNHG4; ceRNA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Humans / Male / Middle aged Idioma: En Revista: J Exp Clin Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google